MétaCan
Menu
Retour à la cohorte
Enregistrement W2021358258 · doi:10.1111/j.1755-3768.2008.01219.x

World Glaucoma Day, 6 March 2008: tackling the glaucoma pandemic

2008· editorial· en· W2021358258 sur OpenAlexaff
Yvonne M. Buys, Ivan Goldberg, George N. Lambrou, Robert Ritch

Notice bibliographique

RevueActa Ophthalmologica · 2008
Typeeditorial
Langueen
DomaineMedicine
ThématiqueGlaucoma and retinal disorders
Établissements canadiensUniversity of Toronto
Organismes subventionnairesnon disponible
Mots-clésGlaucomaMedicineOptometryPopulationPandemicBlindnessDiseaseOphthalmologyCoronavirus disease 2019 (COVID-19)Environmental healthInfectious disease (medical specialty)Internal medicine

Résumé

récupéré en direct d'OpenAlex

We have all heard many times that ‘Glaucoma is the second most common treatable cause of blindness worldwide’. Glaucoma is a significant public health concern, being the leading cause of irreversible vision loss and consistently ranking among the leading causes of blindness in virtually every nation (Quigley & Broman 2006). This is mainly due to low awareness of the disease and its implications. Indeed, it is estimated that only half of those affected by glaucoma in developed nations are aware that they have the disease (Sommer et al. 1991) while as many as 90% of persons with glaucoma in developing countries are unaware of having it or even having heard of it. Despite our better understanding of risk factors for glaucoma, we have yet to see an improvement in these numbers. Although glaucoma occurs in all age groups, it is more common in older adults; with our ageing population, estimates of glaucoma prevalence are increasing. It has been predicted that by 2020, 79.6 million people worldwide will have glaucoma, 11.2 million of whom will be bilaterally blind, up from the current 4.5 million (Quigley & Broman 2006). Recent years have seen considerable progress in the diagnosis and treatment of glaucoma. Technological advances in optic nerve and retinal nerve fibre layer imaging and visual field testing make it possible to diagnose glaucoma in earlier stages, when treatment can significantly improve the prognosis. Medical treatment is available and effective in controlling glaucoma for most patients (Feiner & Piltz-Seymour 2003), while for those uncontrolled, laser and surgical interventions are often successful. Optic nerve and visual field damage are irreversible. Because damage progresses gradually, often unnoticed by the patient, early detection and treatment are of paramount importance to prevent blindness. For individuals with known risk factors for glaucoma – particularly elevated intraocular pressure, increasing age, African descent, family history of glaucoma, vasospasm, low blood pressure and high myopia – the importance of routine examinations cannot be understated. Also, despite strong evidence that lowering intraocular pressure can delay the onset and progression of glaucoma (AGIS Investigators 2000; Heijl et al. 2002; Kass et al. 2002), reported rates of non-compliance with glaucoma therapy range from 5% to 80% (Olthoff et al. 2005). This high variability results from different definitions of non-compliance and the way in which it is measured. The year 2008 is a pivotal one for glaucoma awareness. To combat the ignorance that leads to so much loss of vision, the World Glaucoma Association (WGA) and the World Glaucoma Patient Association (WGPA) have joined forces to launch a global initiative aimed at raising awareness of glaucoma through an annual World Glaucoma Day. They selected 6 March 2008 for the first observance of the day, as a way to jump-start awareness activities and to enlist the active support of governments, eye care professionals and patient support groups in many nations. Rather than have a single large event held in conjunction with a major conference, the day will consist of the sum total of local, regional and national initiatives and events organized by willing groups and individuals around the world. These activities will include: media campaigns; official recognition (three countries will issue commemorative stamps and a delegation from the American Glaucoma Society will visit the US Congress); public-oriented events (e.g. screenings in public places); and institutional events (open-doors day at eye clinics and universities, with lectures addressed to both professional and lay audiences). All these events, together with supporting material, general information on the disease and useful links, are listed at http://www.wgday.net. The public needs to know that there are means for detecting and treating glaucoma and that sight can be saved. They should be made aware of the insidious nature of glaucoma and the importance of compliance with treatment and follow-up to minimize their risk of visual loss. Persons with glaucoma need to inform family members, so that they too can be screened. Healthcare providers, together with governments, should promote public awareness campaigns encouraging regular eye exams, especially for those with known risk factors. Eye-care professionals should take the lead by writing articles for local newspapers, contacting radio stations or organizing public meetings on glaucoma. Earlier diagnosis and treatment will reduce visual disability, improve patient quality of life and decrease overall cost of treatment. The WGA has set a goal of reducing the undiagnosed rate of glaucoma from 50% to ‘‘No more than 20% by 2020’’. This goal is attainable if all parties work together to increase awareness of glaucoma among both the public and healthcare providers, and if we all ensure that quality eye exams are available worldwide. Each of us can help make this a day to remember. The possibilities abound. Groups and individuals around the world have volunteered to organize events of the types described. Others have come up with original ideas: a national ophthalmology journal will publish a special glaucoma issue; other scientific journals will publish editorials on glaucoma; and a group of volunteers will run in the Geneva annual marathon under the WGD colours. In Latin America, a tongue-in-cheek movie has been produced to remind patients humorously that compliance with therapy is the best way to keep the ‘sneak thief of sight’ at bay. The success of World Glaucoma Day also depends on eye-care professionals participating actively at a national level, and developing local strategies to achieve this goal. Every journey begins with a small step, but it is the cumulative number of steps that will determine how far we will go. As World Glaucoma Day approaches, take that first step: ask yourself ‘what can I do?’ and make this campaign a success. The possibilities are endless and the success of the day will depend not only on the number and attendance of events organized globally, but also on their visibility. So to maximize the impact of this initiative, please take a moment to visit http://www.wgday.net and fill out an event submission form under ‘‘Be Part of It’’ and tell the world how you will contribute to the success of the first ever World Glaucoma Day.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,003
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict), Intégrité de la recherche, Charge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesIntégrité de la recherche
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Éditorial · Signal consensuel: Éditorial
Score de désaccord entre enseignants0,085
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,003
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0000,001
Études des sciences et des technologies0,0010,001
Communication savante0,0000,000
Science ouverte0,0010,001
Intégrité de la recherche0,0020,004
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,023
Tête enseignante GPT0,296
Écart entre enseignants0,273 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; les deux têtes enseignantes s’accordent sur ce qui est montré ici.

Devis d'étudeSans objet
Domainenon disponible
GenreÉditorial

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations6
Publié2008
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueActa OphthalmologicaMême sujetGlaucoma and retinal disordersTravaux en français237 207